Saturday 17 October 2026
Export OSUR’s income statement to Excel — free account
OraSure Technologies, Inc.
OSUR Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.61
0.20
−5.25%
Follow OSUR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 3 | 2 |
+8 more TTM periods Free account |
| (14.07%) | (21.16%) | (18.30%) | (15.30%) | ||
| (12.20%) | (17.94%) | (15.57%) | (13.58%) | ||
ROIC |
(21.46%) | (35.48%) | (31.75%) | (27.59%) | |
Return on Tangible Assets |
(20.78%) | (32.00%) | (26.30%) | (21.24%) | |
Average Days of Receivables |
88.84 | 85.31 | 70.46 | 70.56 | |
Free Cash Flow per Share |
(0.71) | (0.70) | (0.72) | (0.59) | |
Free Cash Flow |
(48.83) | (48.66) | (53.22) | (42.76) | |
Capital Expenditures |
(5.95) | (5.48) | (4.20) | (2.84) | |
| Other line items | |||||
Cash ROIC |
(10.21%) | (9.92%) | (9.85%) | (7.39%) | |
Accounts Receivable Turnover |
4.22 | 4.72 | 5.00 | 4.91 | |
Accounts Payable Turnover |
8.73 | 7.08 | 9.10 | 9.40 | |
Inventory Turnover |
2.03 | 1.98 | 2.05 | 2.07 | |
Average Days of Payables |
47.50 | 59.40 | 35.62 | 30.99 | |
Days of Inventory on Hand |
170.03 | 169.37 | 169.66 | 162.75 | |
Tax Rate |
0.00 | 0.03 | 0.03 | 0.04 | |
Research and Development Expense of Revenue |
39.69% | 41.21% | 36.97% | 29.59% | |
Selling, General and Administrative Expense of Revenue |
67.73% | 65.62% | 64.16% | 61.49% | |
Share Based Compensation of Revenue |
8.32% | 9.05% | 8.82% | 9.09% | |
Operating CF/Net income |
0.87 | 0.58 | 0.71 | 0.66 | |
Depreciation/Fixed assets |
0.25 | 0.26 | 0.26 | 0.25 | |
Capex/Depreciation |
(0.62) | (0.56) | (0.41) | (0.28) | |
Revenue per Share |
1.63 | 1.62 | 1.57 | 1.72 | |
Operating CF per Share |
(0.62) | (0.62) | (0.67) | (0.55) | |
Capex per Share |
(0.09) | (0.08) | (0.06) | (0.04) | |
Capex to Sales |
0.05 | 0.05 | 0.04 | 0.02 |
Columns are period end dates